GSK-HZC115805

Study Sponsor: GSK

Study Title

A 12-Week Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate /Vilanterol (FF/VI) Inhalation Powder 100/25mcg Once-Daily via a Novel Dry Powder Inhaler Compared with Tiotropium Bromide Inhalation Powder 18mcg Delivered Once-Daily via the HandiHaler in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Who Have or Are at Risk for Co-morbid Cardiovascular Disease

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

HZC115805

Trial Registry Identification Number(#'s)

NCT01627327 2011-002451-33

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 3

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=115805

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT01627327

Link to study details on EudraCT (if available)

https://www.clinicaltrialsregister.eu/ctr-search/search?query=2011-002451-33

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

November 2015